News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA® Capsules Patents


2/12/2013 10:06:08 AM

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573): Sucampo Pharmaceuticals, Inc. ("Sucampo") announced that it, together with R-Tech Ueno, Ltd., Sucampo AG, and Takeda Pharmaceutical Company Limited ("Takeda") and certain affiliates of Takeda, has filed a patent infringement lawsuit against Anchen Pharmaceuticals, Inc. ("Anchen"), which had filed Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of AMITIZA® (lubiprostone) oral capsules, and certain affiliates of Anchen. (For more details, please refer to Sucampo's release dated February 8, 2013)

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES